-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

How to Follow CH Patients

Program: Spotlight Sessions
Session: The Clone Wars: Myeloid Neoplasia Risk in Clonal Hematopoiesis
Hematology Disease Topics & Pathways:
Research, Clinical trials, Translational Research, Elderly, Clinical Research, Education, Study Population, Human
Sunday, December 8, 2024, 4:30 PM-5:45 PM

Kirsten Gronbaek, MD, PhD, PR

Rigshospitalet, University of Copenhagen, Kirsten Grønbæk, Copenhagen N, Denmark

Disclosures: Gronbaek: Janssen: Research Funding; GSK: Membership on an entity's Board of Directors or advisory committees.

OffLabel Disclosure: I will refer to Clinical trials ongoing in CCUS/LR MDS- metformin , canakinumab, vitamn C, cucumin-IDH inhibitor and others that may be registered in clinical trials. gov before the meeting

See more of: The Clone Wars: Myeloid Neoplasia Risk in Clonal Hematopoiesis
See more of: Spotlight Sessions
<< Previous Presentation | Next Presentation